Australian team makes major breakthrough with asthma treatment, August 4th. According to the Australian website, hospitalization affects the health and life of many Australians.

The Hunter Medical Research Institute of NSW (HMRI) has made a major breakthrough in the treatment of surgery recently. Researchers have used antibiotic drugs for rare lung diseases to treat surgery with success.

Data Sheet: Allowed According to reports, this study has been published in the British “The Lancet” Medical Journal (The Lancet Medical Journal).

Researchers 上海夜网论坛 at HMRI used azithromycin (azithromycin) for panbronchiolitis (panbronchiolitis) for 200 surgeries and a year-long treatment in adults who cannot be controlled by conventional therapies.

  They have taken the drug 3 times a week for almost a year.

It was found that 40% of patients with moderate or severe hypertension were relieved.

Study author Peter Gibson said many people are embarrassed by the benefits of the drug.

A lady told me that she has never felt so good, and she has been suffering for many, many years.

  It is understood that azithromycin is an antibiotic drug that cured panbronchiolitis of the lung disease in the 1980s.

Gibson said it was a rare disease and many people died as a result.

  HMRI researchers have found that azithromycin can also reduce lung expansion problems in hospitalized patients.

Gibson said the main problem with blood pressure is narrowing of the airways, which in turn causes muscle contraction, blood pressure and breathing.

Azithromycin appears to treat lung swelling and mucus problems.

  Surgical patients taking azithromycin develop resistance.

HMRI researchers are currently studying this issue.

Gibson said that we must select patients taking azithromycin and monitor the potential for this treatment.

Original title: Australia team made major breakthrough in treating asthma with drugs for lung diseases